You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA-PK Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • (no location specified)
Jan 14, 2023

Tumors Trial in United States (GSK4524101, Niraparib)

Not yet recruiting
  • Neoplasms
  • San Francisco, California
  • +5 more
Oct 5, 2023

Advanced Solid Tumors Trial in Worldwide (MSC2490484A (M3814), Fractionated RT, Cisplatin)

Completed
  • Advanced Solid Tumors
  • MSC2490484A (M3814)
  • +2 more
  • Fresno, California
  • +25 more
Apr 6, 2022

Locally Advanced Rectal Cancer Trial in Spain, United States (Peposertib 50 mg, Peposertib 100 mg, Peposertib 150 mg)

Completed
Has Results
  • Locally Advanced Rectal Cancer
  • Peposertib 50 mg
  • +5 more
  • Aurora, Colorado
  • +13 more
Jun 9, 2022

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

Not yet recruiting
  • Advanced Breast Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 12, 2022

Advanced Solid Tumors, Chronic Lymphocytic Leukemia Trial in Belgium, Denmark, Netherlands (MSC2490484A (M3814))

Completed
  • Advanced Solid Tumors
  • Chronic Lymphocytic Leukemia
  • MSC2490484A (M3814)
  • Bruxelles, Belgium
  • +6 more
Apr 24, 2020

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)

Recruiting
  • Healthy Adults
  • Daytona Beach, Florida
    Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
Jun 29, 2023

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Healthy Adults Trial in Dallas (Treatment A, Treatment B)

Not yet recruiting
  • Healthy Adults
  • Treatment A
  • Treatment B
  • Dallas, Texas
    Labcorp Clinical Research Unit Inc
May 11, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

Completed
  • Metastatic Breast Cancer
  • +2 more
  • Control group
  • Case group
  • (no location specified)
Jun 16, 2022

Healthy Trial in Neu-Ulm (Tepotinib, Omeprazole)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Aug 22, 2022

Metastatic Pancreatic Cancer Trial in Spain (OMO-103, Nab-Paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Cancer
  • L´Hospitalet de Llobregat, Barcelona, Spain
  • +3 more
Sep 22, 2023

Advanced Cancer Trial in Belgium, France (AsiDNA)

Completed
  • Advanced Cancer
  • Bruxelles, Belgium
  • +4 more
Mar 23, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Male, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in China (SS109)

Not yet recruiting
  • Male
  • +3 more
  • Hefei, China
  • +8 more
Aug 24, 2023

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer Trial in Worldwide (CC-115)

Completed
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +16 more
Oct 4, 2021

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

Healthy Volunteers Trial (Brensocatib, Rifampin, Esomeprazole)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Apr 12, 2023

HBV Reactivation Between High HBV-DNA and Low HBV-DNA Loads

Recruiting
  • Hepatocellular Carcinoma
  • ICI
  • Antiviral Prophylaxis
  • Guangzhou, Guangdong, China
  • +3 more
Jan 4, 2022

Influenza, Human Trial in Leiden (POLB 001, Placebo)

Completed
  • Influenza, Human
  • POLB 001
  • Placebo
  • Leiden, Netherlands
    Centre for Human Drug Research
Mar 13, 2023

Advanced Solid Tumors, NSCLC, Triple-negative Breast Cancer Trial in Barcelona, Madrid (OMO-103)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • OMO-103
  • Barcelona, Spain
  • +2 more
Sep 27, 2022